Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Jaguar Health (JAGX) Accumulated Depreciation & Amortization (2016 - 2025)

Jaguar Health (JAGX) has disclosed Accumulated Depreciation & Amortization for 11 consecutive years, with $536000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization changed N/A to $536000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $536000.0, a N/A change, with the full-year FY2024 number at $513000.0, up 10.32% from a year prior.
  • Accumulated Depreciation & Amortization was $536000.0 for Q2 2025 at Jaguar Health, up from $525000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $536000.0 in Q2 2025 to a low of $298000.0 in Q4 2021.
  • A 5-year average of $450000.0 and a median of $452000.0 in 2022 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: surged 35.57% in 2022, then grew 10.32% in 2024.
  • Jaguar Health's Accumulated Depreciation & Amortization stood at $298000.0 in 2021, then surged by 35.57% to $404000.0 in 2022, then grew by 15.1% to $465000.0 in 2023, then increased by 10.32% to $513000.0 in 2024, then increased by 4.48% to $536000.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Accumulated Depreciation & Amortization are $536000.0 (Q2 2025), $525000.0 (Q1 2025), and $513000.0 (Q4 2024).